Xilio Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning and welcome to the 21st Needham healthcare conference. My name is Chang Liu, and I will be the moderator for this presentation. It is our pleasure to have Xilio Therapeutics here today and its CMO, Martin Huber. (Conference Instructions)
Without further ado, Martin, would you like to start your presentation?
Thank you, Chang. Good morning. I'm Martin Huber; I'm the President of R&D and Chief Medical Officer at Xilio Therapeutics.
Just by way a quick introduction, I've been with Xilio now for about two years. Prior to that, I was the Chief Medical Officer at Tesaro. You may recall, we had July -- as well as three I-O agents. Prior to that, I was the Merck Keytruda lung cancer program lead for the initial filings in lung cancer. And I've held multiple jobs in the industry. I'm a medical oncologist by training out of the M.D. Anderson Cancer Center.
So what I'd like to share with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
